A Non-Interventional Multi-country Study to Evaluate the Real World Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 10 Oct 2017 Planned End Date changed from 1 Oct 2016 to 30 Nov 2017.
- 10 Oct 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated